Success Metrics

Clinical Success Rate

89.9%

Based on 205 completed trials

Completion Rate

90%(205/228)

Active Trials

95(24%)

Results Posted

18%(36 trials)

Terminated

23(6%)

Phase Distribution

Ph not_applicable

23%

Ph phase_1

Ph phase_3

Ph phase_4

Ph early_phase_1

Ph phase_2

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution143 total trials

Early Phase 1First-in-human

2(1.4%)

Phase 1Safety & dosage

15(10.5%)

Phase 2Efficacy & side effects

12(8.4%)

Phase 3Large-scale testing

6(4.2%)

Phase 4Post-market surveillance

14(9.8%)

N/ANon-phased studies

94(65.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

82.0%

205 of 250 finished

Non-Completion Rate

18.0%

45 ended early

Currently Active

trials recruiting

Total Trials

402

all time

Status Distribution

Active(109)

Completed(205)

Terminated(45)

Other(43)

Detailed Status

Completed205

Recruiting70

unknown41

Active, not recruiting25

Terminated23

Withdrawn22

Development Timeline

Analytics

Development Status

Total Trials

402

Active

Success Rate

89.9%

Most Advanced

Phase 4

Trials by Phase

Early Phase 12 (1.4%)

Phase 115 (10.5%)

Phase 212 (8.4%)

Phase 36 (4.2%)

Phase 414 (9.8%)

N/A94 (65.7%)

Trials by Status

active_not_recruiting256%

enrolling_by_invitation31%

suspended20%

not_yet_recruiting113%

unknown4110%

terminated236%

completed20551%

recruiting7017%

withdrawn225%

Recent Activity

95 active trials

Showing 5 of 402

active_not_recruiting

Transforming Research and Clinical Knowledge in Traumatic Brain Injury Epileptogenesis Project (TRACK-TBI EPI)

NCT05823766

recruiting

Clinical Trials (402)

Showing 20 of 402 trialsScroll for more

NCT05823766

Transforming Research and Clinical Knowledge in Traumatic Brain Injury Epileptogenesis Project (TRACK-TBI EPI)

Active Not Recruiting

NCT07046936

Role of Mitochondrial Bioenergetics in Resilience for Gynecologic Cancer

Recruiting

NCT03235414Not Applicable

Normal Liver Stiffness by MR Elastography

Completed

NCT04809363Phase 4

A Study of CDPATH™ to Help Manage and Treat Crohn's Disease

Active Not Recruiting

NCT05079399

Biomarker of Diabetic Retinopathy

Recruiting

NCT03334708

A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma

Recruiting

NCT03958747Not Applicable

Ultrasound for the Detection of Oxaliplatin-Induced Peripheral Neuropathy

Completed

NCT03996239Not Applicable

Researching the Effect of Aerobic Exercise on Cancer

Active Not Recruiting

NCT06710964Not Applicable

Inducing Self-Dehumanization to Examine Oxytocin and Suicide Risk

Not Yet Recruiting

NCT07705789Not Applicable

The Role of interferOn and Complement in SecondAry thRombotic micrioangiOpathy

Not Yet Recruiting

NCT06976502

Health eHeart BioBank

Enrolling By Invitation

NCT06480591

Evaluation of the Pathobiology of CALR-mutated MPN Cells

Recruiting

NCT06836141

Biomarkers for Cognitive Decline in Intracerebral Hemorrhage

Recruiting

NCT07270666Not Applicable

ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer

Recruiting

NCT04331067Phase 1

Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer

Terminated

NCT06660108Not Applicable

MOLECULAR BASIS OF LANGUAGE DEVELOPMENT AND ASSOCIATED DISORDERS

Recruiting

NCT07132788Not Applicable

Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass

Recruiting

NCT05787470

State of Hormones Impact Nociceptive Expression

Recruiting

NCT05397132

Mechanisms of Disease R/R in CAR-T for Hematologic Malignancies

Completed

NCT01385176Not Applicable

Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)

Active Not Recruiting

Drug Details

Intervention Type: PROCEDURE
Total Trials: 402